Literature DB >> 27721057

The use of EORTC measures in daily clinical practice-A synopsis of a newly developed manual.

Lisa M Wintner1, Monika Sztankay2, Neil Aaronson3, Andrew Bottomley4, Johannes M Giesinger5, Mogens Groenvold6, Morten Aa Petersen7, Lonneke van de Poll-Franse8, Galina Velikova9, Irma Verdonck-de Leeuw10, Bernhard Holzner11.   

Abstract

Cancer has increasingly become a chronic condition and the routine collection of patient-reported outcomes (PROs) like quality of life is widely recommended for clinical practice. Nonetheless, the successful implementation of PROs is still a major challenge, although common barriers to and facilitators of their beneficial use are well known. To support health care professionals and other stakeholders in the implementation of the EORTC PRO measures, the EORTC Quality of Life Group provides guidance on issues considered important for their use in daily clinical practice. Herein, we present an outline of the newly developed "'Manual for the use of EORTC measures in daily clinical practice", covering the following issues: * a rationale for using EORTC measures in routine care *selection of EORTC measures, timing of assessments, scoring and presentation of results * aspects of a strategic implementation * electronic data assessment and telemonitoring, and * further use of EORTC measures and ethical considerations. Next to an extensive overview of currently available literature, the manual specifically focuses on knowledge about EORTC measures to give evidence-based recommendations whenever possible and to encourage readers and end-users of EORTC measures to contribute to further needed high-quality research. The manual will be accessible on the EORTC Quality of Life Group website's homepage and will be periodically updated to take into account any new knowledge due to medical, technical, regulatory and scientific advances.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Daily clinical routine; EORTC Quality of Life Group; Guideline; Implementation; Manual; Neoplasms; Patient-reported outcomes; Quality of life

Mesh:

Year:  2016        PMID: 27721057     DOI: 10.1016/j.ejca.2016.08.024

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  30 in total

1.  Which symptoms and problems do advanced cancer patients admitted to specialized palliative care report in addition to those included in the EORTC QLQ-C15-PAL? A register-based national study.

Authors:  Leslye Rojas-Concha; Maiken Bang Hansen; Morten Aagaard Petersen; Mogens Groenvold
Journal:  Support Care Cancer       Date:  2019-07-11       Impact factor: 3.603

2.  Measuring health-related quality of life in patients with advanced cancer: a systematic review of self-administered measurement instruments.

Authors:  Janneke van Roij; Heidi Fransen; Lonneke van de Poll-Franse; Myrte Zijlstra; Natasja Raijmakers
Journal:  Qual Life Res       Date:  2018-02-10       Impact factor: 4.147

3.  Feasibility and acceptability of a psychosocial and adherence electronic patient reported outcomes (PROs) system at an HIV care center in southern India.

Authors:  Nishita Sinha; Andrew Yang; Amrose Pradeep; R Bhuvaneswari; Nagalingeswaran Kumarasamy; Conall O'Cleirigh; Kenneth H Mayer; Brian T Chan
Journal:  AIDS Care       Date:  2019-09-18

4.  Nausea in advanced cancer: relationships between intensity, burden, and the need for help.

Authors:  Signe Ladegaard Harder; Mogens Groenvold; Jørn Herrstedt; Anna Thit Johnsen
Journal:  Support Care Cancer       Date:  2018-06-26       Impact factor: 3.603

5.  Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice.

Authors:  Guillaume Mouillet; Antoine Falcoz; Joëlle Fritzsch; Hamadi Almotlak; Pascale Jacoulet; Xavier Pivot; Cristian Villanueva; Laura Mansi; Stefano Kim; Elsa Curtit; Nathalie Meneveau; Olivier Adotevi; Marine Jary; Guillaume Eberst; Angelique Vienot; Fabien Calcagno; Astrid Pozet; Oumelkheir Djoumakh; Christophe Borg; Virginie Westeel; Amélie Anota; Sophie Paget-Bailly
Journal:  Qual Life Res       Date:  2021-01-02       Impact factor: 4.147

6.  Health-related quality of life among cancer patients in their last year of life: results from the PROFILES registry.

Authors:  Natasja J H Raijmakers; M Zijlstra; J van Roij; O Husson; S Oerlemans; L V van de Poll-Franse
Journal:  Support Care Cancer       Date:  2018-04-16       Impact factor: 3.603

7.  Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy.

Authors:  Maarten J van der Doelen; Irma M Oving; Dirk N J Wyndaele; Jean-Paul van Basten; Frederiek Terheggen; Addy C M van de Luijtgaarden; Wim J G Oyen; W Dick van Schelven; Franchette van den Berkmortel; Niven Mehra; Marcel J R Janssen; Judith B Prins; Winald R Gerritsen; José A E Custers; Inge M van Oort
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-07-08       Impact factor: 5.554

8.  An implementation study of electronic assessment of patient-reported outcomes in inpatient radiation oncology.

Authors:  Thomas Nordhausen; Katharina Lampe; Dirk Vordermark; Bernhard Holzner; Haifa-Kathrin Al-Ali; Gabriele Meyer; Heike Schmidt
Journal:  J Patient Rep Outcomes       Date:  2022-07-19

9.  Using the Computer-based Health Evaluation System (CHES) to Support Self-management of Symptoms and Functional Health: Evaluation of Hematological Patient Use of a Web-Based Patient Portal.

Authors:  Jens Lehmann; Petra Buhl; Johannes M Giesinger; Lisa M Wintner; Monika Sztankay; Lucia Neppl; Wolfgang Willenbacher; Roman Weger; Walpurga Weyrer; Gerhard Rumpold; Bernhard Holzner
Journal:  J Med Internet Res       Date:  2021-06-08       Impact factor: 5.428

10.  Applying the thresholds for clinical importance for fourteen key domains of the EORTC QLQ-C30: a latent class analysis of cancer survivors.

Authors:  Laura Keaver; Christopher McLaughlin
Journal:  Support Care Cancer       Date:  2021-06-25       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.